Dongyue Group Ltd (0189)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 9.810 |
|---|---|
| 52-week range | 9.244 – 23.740 |
| Return, 1 month / 3 months | −17.5% / −22.1% |
| Return, 1 year / 3 years | −20.7% / +75.4% |
| Trend | Below its 200-day average |
| RSI (14) | 24 |
| Volatility (1 year) | 59.1% |
| Worst drawdown (1 year) | -56.1% |
| Average daily value traded | 260.28M HKD |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dongyue Group is a Chinese chemicals company based in Shandong province. It makes silicone materials, fluorochemical products and refrigerants, serving industrial customers in China and abroad. Its products are used in construction, electronics, automotive and appliance manufacturing, among other industries. The company also produces polymer and chlor-alkali related materials as part of its chemical operations.
Dongyue Group Ltd trades under the code 0189 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dongyue Group Ltd (0189) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 9.810 on 21 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 1,394 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.7% and over the last three months it fell 22.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.5% | ||
| From 52-week high | -56.1% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -22.1% | ||
| 6-month return | -15.4% | ||
| 12-month return, skipping the last month | -3.8% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 59.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -56.1% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 260.28M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −8.9% |
|---|---|
| 1 month | −17.5% |
| 3 months | −22.1% |
| 6 months | −15.4% |
| 1 year | −20.7% |
| 3 years | +75.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.098 / 12.999 |
|---|---|
| Golden / death cross (60 days) | Death, 22 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.446 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jun 2026 | HKD 0.3000 |
| 10 Jun 2025 | HKD 0.1000 |
| 11 Jun 2024 | HKD 0.1000 |
| 14 Jun 2023 | HKD 0.6000 |
| 14 Jun 2022 | HKD 0.3400 |
| 15 Jun 2021 | HKD 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.